Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. | Reporting Person's title: Executive Vice President Chief Commercial Officer | Common Stock | 138K | $979K | $7.11 | Nov 30, 2024 | Direct |
Arcutis Biotherapeutics, Inc. | Reporting Person's title: Executive Vice President Chief Commercial Officer | Stock Option (right to buy) | 176K | Jan 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARQT | Arcutis Biotherapeutics, Inc. | Nov 30, 2024 | 1 | $7.77K | 4 | Dec 3, 2024 | Reporting Person's title: Executive Vice President Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Oct 2, 2024 | 1 | -$37.3K | 4 | Oct 3, 2024 | SVP Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | May 16, 2024 | 2 | -$68.6K | 4 | May 20, 2024 | SVP Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Jan 12, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Sep 27, 2023 | 2 | $0 | 4 | Oct 3, 2023 | Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Sep 27, 2023 | 0 | $0 | 3 | Oct 3, 2023 | Chief Commercial Officer |